HTG Molecular Diagnostics
HTGM
$0.48
Share price
0.00%
Change (1 day)
-96.26%
Change (1 year)
Categories
HTG Molecular Diagnostics (HTGM) - Total assets
Total assets on the balance sheet as of March 2023 : $10.86 M
According to HTG Molecular Diagnostics 's latest financial reports the company's total assets are $10.86 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
HTG Molecular Diagnostics - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $17.77 M | -41.64% |
| 2021-12-31 | $30.46 M | -13.46% |
| 2020-12-31 | $35.19 M | -21.99% |
| 2019-12-31 | $45.11 M | 3.08% |
| 2018-12-31 | $43.77 M | 105.92% |
| 2017-12-31 | $21.25 M | 15.18% |
| 2016-12-31 | $18.45 M | -53.22% |
| 2015-12-31 | $39.44 M | 351.94% |
| 2014-12-31 | $8.72 M | 98.47% |
| 2013-12-31 | $4.39 M | -47.85% |
| 2012-12-31 | $8.43 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.22 B | 2,011.52% | 🇺🇸 USA |
 Affimed
AFMD | $0.10 B | 888.58% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | $28.67 M | 163.92% | 🇺🇸 USA |